Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous subcutaneous lisuride infusion in OPCA.

A Heinz1, J Wöhrle, L Schöls

  • 1Department of Neurology, St. Josef Hospital, Ruhr University, Bochum, Federal Republic of Germany.

Journal of Neural Transmission. General Section
|January 1, 1992
PubMed
Summary

Continuous subcutaneous lisuride infusion improved Parkinsonism symptoms in four patients with sporadic olivopontocerebellar atrophy (OPCA). This treatment offered sustained benefits for at least six months, suggesting a viable option when oral therapies fail.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline characteristics of a diagnostically defined early psychosis cohort entering supported employment and education: findings from the SEEearly trial.

European archives of psychiatry and clinical neuroscience·2026
Same author

Direct Evidence for the νd_{5/2} Orbital in ^{69}Ni: Implications for the N=40 Island of Inversion.

Physical review letters·2026
Same author

Author Correction: An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

First Measurement of the Neutron-Emission Probability with a Surrogate Reaction in Inverse Kinematics at a Heavy-Ion Storage Ring.

Physical review letters·2025
Same author

Craving induction through virtual reality cue-exposure for patients with alcohol dependence in rehabilitation treatment.

Scientific reports·2024

Area of Science:

  • Neurology
  • Neurodegenerative Diseases
  • Pharmacology

Background:

  • Sporadic olivopontocerebellar atrophy (OPCA) is a rare neurodegenerative disorder.
  • Patients with OPCA often exhibit severe Parkinsonism, significantly impacting motor function.
  • Existing oral dopaminergic treatments may have limitations in managing advanced symptoms.

Purpose of the Study:

  • To evaluate the efficacy and safety of continuous subcutaneous lisuride infusion in OPCA patients with Parkinsonism.
  • To determine the duration of therapeutic benefit and identify potential treatment limitations.

Main Methods:

  • Four patients with sporadic OPCA and Parkinsonism were enrolled.
  • Continuous subcutaneous lisuride infusion was administered via an external pump.

Related Experiment Videos

  • Patients were monitored for motor performance, dysphagia, and dysarthria over a 6-month follow-up period.

    • Main Results:

    • All four patients demonstrated benefit from the lisuride infusion.
    • Three patients experienced overall improvement in motor performance.
    • One patient showed significant improvement in dysphagia and dysarthria.
    • Therapeutic benefits were sustained for at least six months.
    • A daily dose of 1.0 mg led to oropharyngeal dystonia (dysphagia) in one patient, indicating a dose-limiting side effect.

    Conclusions:

    • Continuous subcutaneous lisuride infusion is a promising therapeutic option for OPCA patients with Parkinsonism.
    • This treatment can provide sustained motor and non-motor symptom relief when oral dopaminergic therapy is ineffective.
    • Careful dose titration is necessary to manage potential side effects like oropharyngeal dystonia.